Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Dr. Tselios, et al, reply.

Tselios K, Gladman DD, Harvey P, Akhtari S, Su J, Urowitz MB.

J Rheumatol. 2019 Jul 1. pii: jrheum.190255. doi: 10.3899/jrheum.190255. [Epub ahead of print]

PMID:
31263072
2.

All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013).

Tselios K, Gladman DD, Sheane BJ, Su J, Urowitz M.

Ann Rheum Dis. 2019 Jun;78(6):802-806. doi: 10.1136/annrheumdis-2018-214802. Epub 2019 Apr 16.

PMID:
30992296
3.

Disease course patterns in systemic lupus erythematosus.

Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB.

Lupus. 2019 Jan;28(1):114-122. doi: 10.1177/0961203318817132. Epub 2018 Dec 8.

PMID:
30526328
4.

Correction to: Psoriasis in systemic lupus erythematosus: a single-center experience.

Tselios K, Yap KS, Pakchotanon R, Polachek A, Su J, Urowitz MB, Gladman DD.

Clin Rheumatol. 2019 Jan;38(1):269. doi: 10.1007/s10067-018-4363-0.

PMID:
30430267
5.

How can we define low disease activity in systemic lupus erythematosus?

Tselios K, Gladman DD, Urowitz MB.

Semin Arthritis Rheum. 2019 Jun;48(6):1035-1040. doi: 10.1016/j.semarthrit.2018.10.013. Epub 2018 Oct 16.

PMID:
30415943
6.

Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?

Tselios K, Deeb M, Gladman DD, Harvey P, Akhtari S, Mak S, Butany J, Urowitz MB.

J Rheumatol. 2019 Apr;46(4):391-396. doi: 10.3899/jrheum.180124. Epub 2018 Oct 15.

PMID:
30323009
7.

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.

Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman DD, Haaland D, Hanly JG, Hiraki LT, Hussein S, Legault K, Levy D, Lim L, Matsos M, McDonald EG, Medina-Rosas J, Pardo Pardi J, Peschken C, Pineau C, Pope J, Rader T, Reynolds J, Silverman E, Tselios K, Suitner M, Urowitz M, Touma Z, Vinet E, Santesso N.

J Rheumatol. 2018 Oct;45(10):1426-1439. doi: 10.3899/jrheum.171459. Epub 2018 Sep 1.

8.

Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?

Tselios K, Gladman DD, Harvey P, Akhtari S, Su J, Urowitz MB.

J Rheumatol. 2019 Jan;46(1):64-69. doi: 10.3899/jrheum.171436. Epub 2018 Aug 1.

PMID:
30068764
9.

Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.

Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB.

Arthritis Care Res (Hoboken). 2019 Jun;71(6):822-828. doi: 10.1002/acr.23720. Epub 2019 May 10.

PMID:
30055090
10.

Monophasic Disease Course in Systemic Lupus Erythematosus.

Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB.

J Rheumatol. 2018 Aug;45(8):1131-1135. doi: 10.3899/jrheum.171319. Epub 2018 Jun 1.

PMID:
29858240
11.

Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors.

Tselios K, Gladman DD, Harvey P, Su J, Urowitz MB.

Lupus. 2018 Aug;27(9):1415-1423. doi: 10.1177/0961203318770526. Epub 2018 Apr 17.

PMID:
29665757
12.

Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies.

Tanwani J, Tselios K, Gladman DD, Su J, Urowitz MB.

Lupus. 2018 Jul;27(8):1296-1302. doi: 10.1177/0961203318770018. Epub 2018 Apr 11.

PMID:
29642752
13.

Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study.

Tselios K, Gladman DD, Su J, Ace O, Urowitz MB.

J Rheumatol. 2017 Dec;44(12):1841-1849. doi: 10.3899/jrheum.161121. Epub 2017 Nov 1.

PMID:
29093154
14.

Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis.

Tselios K, Lam WC, Urowitz MB, Gladman DD.

J Clin Rheumatol. 2018 Mar;24(2):93-94. doi: 10.1097/RHU.0000000000000600. No abstract available. Erratum in: J Clin Rheumatol. 2018 Jun;24(4):192.

PMID:
29059086
15.

Discrepancies in reference values of soluble Triggering Receptor Expressed on Myelocytes 1 (sTREM-1) question the reliability of related studies.

Gkougkourelas I, Tselios K, Boura P.

Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12849. Epub 2017 Nov 8. No abstract available.

PMID:
29047104
16.

Antimalarial-induced cardiomyopathy: a systematic review of the literature.

Tselios K, Deeb M, Gladman DD, Harvey P, Urowitz MB.

Lupus. 2018 Apr;27(4):591-599. doi: 10.1177/0961203317734922. Epub 2017 Oct 9. Review.

PMID:
28992800
17.

Shrinking lung syndrome in systemic lupus erythematosus: a single-centre experience.

Deeb M, Tselios K, Gladman DD, Su J, Urowitz MB.

Lupus. 2018 Mar;27(3):365-371. doi: 10.1177/0961203317722411. Epub 2017 Jul 31.

PMID:
28758573
18.

Cardiovascular and Pulmonary Manifestations of Systemic Lupus Erythematosus.

Tselios K, Urowitz MB.

Curr Rheumatol Rev. 2017;13(3):206-218. doi: 10.2174/1573397113666170704102444. Review.

PMID:
28675998
19.

Psoriasis in systemic lupus erythematosus: a single-center experience.

Tselios K, Yap KS, Pakchotanon R, Polachek A, Su J, Urowitz MB, Gladman DD.

Clin Rheumatol. 2017 Apr;36(4):879-884. doi: 10.1007/s10067-017-3566-0. Epub 2017 Feb 6. Erratum in: Clin Rheumatol. 2019 Jan;38(1):269.

PMID:
28168661
20.

Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies.

Tselios K, Gladman DD, Urowitz MB.

Open Access Rheumatol. 2016 Dec 20;9:1-9. doi: 10.2147/OARRR.S123549. eCollection 2017. Review.

21.

Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus.

Tziomalos K, Gkougkourelas I, Sarantopoulos A, Bekiari E, Makri E, Raptis N, Tselios K, Pantoura M, Hatzitolios AI, Boura P.

Rheumatol Int. 2017 Feb;37(2):293-298. doi: 10.1007/s00296-016-3610-4. Epub 2016 Nov 21.

PMID:
27873008
22.

Dr. Tselios, et al reply.

Tselios K, Gladman DD, Su J, Urowitz MB.

J Rheumatol. 2016 Sep;43(9):1767. doi: 10.3899/jrheum.160749. No abstract available.

PMID:
27587017
23.

Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus.

Tselios K, Gladman DD, Harvey P, Mak S, Chantal M, Butany J, Urowitz MB.

J Clin Rheumatol. 2016 Aug;22(5):287-8. doi: 10.1097/RHU.0000000000000400. No abstract available.

PMID:
27464781
24.

Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case-Control Study.

Tselios K, Gladman DD, Su J, Urowitz MB.

Arthritis Care Res (Hoboken). 2016 Oct;68(10):1497-504. doi: 10.1002/acr.22857. Epub 2016 Aug 19.

25.

Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.

Tselios K, Gladman DD, Su J, Urowitz MB.

J Rheumatol. 2016 Mar;43(3):552-8. doi: 10.3899/jrheum.150779. Epub 2016 Jan 15.

PMID:
26773121
26.

Dyslipidemia in systemic lupus erythematosus: just another comorbidity?

Tselios K, Koumaras C, Gladman DD, Urowitz MB.

Semin Arthritis Rheum. 2016 Apr;45(5):604-10. doi: 10.1016/j.semarthrit.2015.10.010. Epub 2015 Oct 29. Review.

PMID:
26711309
27.

Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus.

Tselios K, Gladman DD, Su J, Urowitz MB.

Lupus. 2016 Apr;25(5):532-5. doi: 10.1177/0961203315617845. Epub 2015 Nov 18.

PMID:
26585070
28.

Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review.

Tselios K, Sheane BJ, Gladman DD, Urowitz MB.

J Rheumatol. 2016 Jan;43(1):54-65. doi: 10.3899/jrheum.150460. Epub 2015 Nov 15. Review.

PMID:
26568591
29.

Increase of peripheral T regulatory cells during remission induction with cyclophosphamide in active systemic lupus erythematosus.

Tselios K, Sarantopoulos A, Gkougkourelas I, Papagianni A, Boura P.

Int J Rheum Dis. 2014 Sep;17(7):790-5. doi: 10.1111/1756-185X.12500.

PMID:
25430593
30.

T regulatory cells: a promising new target in atherosclerosis.

Tselios K, Sarantopoulos A, Gkougkourelas I, Boura P.

Crit Rev Immunol. 2014;34(5):389-97. Review.

PMID:
25404046
31.

Systemic sclerosis and silicone breast implant: a case report and review of the literature.

Psarras A, Gkougkourelas I, Tselios K, Sarantopoulos A, Boura P.

Case Rep Rheumatol. 2014;2014:809629. doi: 10.1155/2014/809629. Epub 2014 Sep 30.

32.

The influence of therapy on CD4+CD25(high)FOXP3+ regulatory T cells in systemic lupus erythematosus patients: a prospective study.

Tselios K, Sarantopoulos A, Gkougkourelas I, Boura P.

Scand J Rheumatol. 2015;44(1):29-35. doi: 10.3109/03009742.2014.922214. Epub 2014 Sep 10.

PMID:
25205084
33.

CD4+CD25highFOXP3+ T regulatory cells as a biomarker of disease activity in systemic lupus erythematosus: a prospective study.

Tselios K, Sarantopoulos A, Gkougkourelas I, Boura P.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):630-9. Epub 2014 Sep 8.

PMID:
25197969
34.

Tocilizumab treatment leads to a rapid and sustained increase in Treg cell levels in rheumatoid arthritis patients: comment on the article by Thiolat et al.

Sarantopoulos A, Tselios K, Gkougkourelas I, Pantoura M, Georgiadou AM, Boura P.

Arthritis Rheumatol. 2014 Sep;66(9):2638. doi: 10.1002/art.38714. No abstract available.

35.

Images in vascular medicine. Celiac trunk aneurysm in a patient with Adamantiades-Behcet disease.

Tselios K, Chatzicharalampous KG, Gkougkourelas I, Sarantopoulos A, Boura P.

Vasc Med. 2014 Feb;19(1):77-8. doi: 10.1177/1358863X13515767. Epub 2013 Dec 13. No abstract available.

PMID:
24335025
36.

Fatal refractory thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus.

Tselios K, Klonizakis P, Sarantopoulos A, Gkougkourelas I, Boura P.

J Clin Rheumatol. 2013 Oct;19(7):412-4. doi: 10.1097/RHU.0b013e3182a703bf. No abstract available.

PMID:
24048105
37.

Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal.

Tselios K, Koumaras C, Urowitz MB, Gladman DD.

Semin Arthritis Rheum. 2014 Feb;43(4):521-5. doi: 10.1016/j.semarthrit.2013.07.007. Epub 2013 Aug 15.

PMID:
23953498
38.

The role of anti-phosphatidylserine/prothrombin antibodies in thrombotic manifestations of systemic lupus erythematosus patients.

Tselios K, Sarantopoulos A, Gkougkourellas I, Boura P.

Front Neurol. 2013 Jun 4;4:66. doi: 10.3389/fneur.2013.00066. eCollection 2013. No abstract available.

39.

ADAMTS-13 metalloprotease abnormalities in systemic lupus erythematosus: is there a correlation with disease status?

Klonizakis P, Tselios K, Sarantopoulos A, Gougourellas I, Rouka E, Onufriadou Z, Kapali P, Kyriakou D, Boura P.

Lupus. 2013 Apr;22(5):443-52. doi: 10.1177/0961203313477898.

PMID:
23554033
40.

Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report.

Tselios K, Tsioka R, Sarantopoulos A, Mouloudi E, Boura P.

BMC Infect Dis. 2011 Dec 29;11:358. doi: 10.1186/1471-2334-11-358.

41.

Chronic brucellosis patients retain low frequency of CD4+ T-lymphocytes expressing CD25 and CD28 after Escherichia coli LPS stimulation of PHA-cultured PBMCs.

Skendros P, Sarantopoulos A, Tselios K, Boura P.

Clin Dev Immunol. 2008;2008:327346. doi: 10.1155/2008/327346. Epub 2009 Jan 25.

42.

Genetic polymorphism study of regulatory B cell molecules and cellular immunity function in an adult patient with Common Variable Immunodeficiency.

Sarantopoulos A, Tselios K, Skendros P, Bougiouklis D, Theodorou I, Boura P.

Hippokratia. 2008 Jul;12(3):188-90.

43.

Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report.

Vlachaki E, Tselios K, Charalambidou S, Ioannidou E, Klonizakis I.

Int J Hematol. 2008 Oct;88(3):341-342. doi: 10.1007/s12185-008-0158-4. Epub 2008 Sep 3. No abstract available.

PMID:
18766306
44.

Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature.

Vlachaki E, Tselios K, Perifanis V, Tsatra I, Tsayas I.

Clin Rheumatol. 2008 Nov;27(11):1459-61. doi: 10.1007/s10067-008-0969-y. Epub 2008 Jul 29. Review.

PMID:
18663554
45.

Adamantiades-Behcet disease (ABD) in northern Greece patients: experience from a single center.

Boura P, Tselios K, Skendros P, Kamali S, Sarantopoulos A, Raptopoulou-Gigi M.

Hippokratia. 2007 Oct;11(4):210-5.

46.

Yersinia enterocolitica O:3 mesenteric lymphadenopathy in an apparently healthy adult.

Vlachaki E, Tselios K, Tsapas A, Klonizakis J.

Neth J Med. 2007 Sep;65(8):311-2. No abstract available.

47.

Concurrent relapsing central nervous system and ocular involvement in a case of life-threatening Adamantiades-Beh├žet Disease (ABD).

Boura P, Tselios K, Kamali S, Skendros P, Sarantopoulos A, Topouzis F.

Neurol Sci. 2006 Dec;27(6):432-5.

PMID:
17205230
48.

Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case.

Boura P, Papadopoulos S, Tselios K, Skendros P, Dioritou O, Malamis G, Makris P, Lefkos N.

Clin Rheumatol. 2005 Aug;24(4):420-4. Epub 2005 May 24.

PMID:
15912267
49.

Antiphospholipid syndrome in Greece: clinical and immunological study and review of the literature.

Boura P, Tselios K, Skendros P, Kountouras J.

Angiology. 2004 Jul-Aug;55(4):421-30. Review.

PMID:
15258688

Supplemental Content

Loading ...
Support Center